Literature DB >> 33310737

11C Dosimetry Scans Should Be Abandoned.

Paolo Zanotti-Fregonara1, Adriaan A Lammertsma2, Robert B Innis3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33310737      PMCID： PMC9364868          DOI： 10.2967/jnumed.120.257402

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  10 in total

1.  Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer.

Authors:  Joseph A O'Donoghue; Jason S Lewis; Neeta Pandit-Taskar; Stephen E Fleming; Heiko Schöder; Steven M Larson; Volkan Beylergil; Shutian Ruan; Serge K Lyashchenko; Pat B Zanzonico; Wolfgang A Weber; Jorge A Carrasquillo; Yelena Y Janjigian
Journal:  J Nucl Med       Date:  2017-06-21       Impact factor: 10.057

2.  Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).

Authors:  Charles M Laymon; Rajesh Narendran; Neale S Mason; Jonathan P Carney; Brian J Lopresti; Chester A Mathis; James M Mountz; Donald Sashin; W Gordan Frankle
Journal:  Mol Imaging Biol       Date:  2012-02       Impact factor: 3.488

3.  Biodistribution and radiation dosimetry of 11C-WAY100,635 in humans.

Authors:  Ramin V Parsey; Marie-Jose Belanger; Gregory M Sullivan; Norman R Simpson; Michael G Stabin; Ronald Van Heertum; J John Mann
Journal:  J Nucl Med       Date:  2005-04       Impact factor: 10.057

4.  Suggested pathway to assess radiation safety of ¹⁸F-labeled PET tracers for first-in-human studies.

Authors:  Paolo Zanotti-Fregonara; Adriaan A Lammertsma; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-19       Impact factor: 9.236

5.  Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.

Authors:  Mohan Doss; Hartmuth C Kolb; Joseph C Walsh; Vani Mocharla; Hong Fan; Ashok Chaudhary; Zhihong Zhu; R Katherine Alpaugh; Miriam N Lango; Jian Q Yu
Journal:  J Nucl Med       Date:  2013-10-17       Impact factor: 10.057

6.  First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.

Authors:  Neeta Pandit-Taskar; Joseph A O'Donoghue; Shutian Ruan; Serge K Lyashchenko; Jorge A Carrasquillo; Glenn Heller; Danny F Martinez; Sarah M Cheal; Jason S Lewis; Martin Fleisher; Jennifer S Keppler; Robert E Reiter; Anna M Wu; Wolfgang A Weber; Howard I Scher; Steven M Larson; Michael J Morris
Journal:  J Nucl Med       Date:  2016-08-11       Impact factor: 10.057

7.  18F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients.

Authors:  Jim O'Doherty; Maite Jauregui-Osoro; Teresa Brothwood; Teresa Szyszko; Paul K Marsden; Michael J O'Doherty; Gary J R Cook; Philip J Blower; Val Lewington
Journal:  J Nucl Med       Date:  2017-04-06       Impact factor: 10.057

8.  Human biodistribution and dosimetry of ¹¹C-CUMI-101, an agonist radioligand for serotonin-1a receptors in brain.

Authors:  Christina S Hines; Jeih-San Liow; Paolo Zanotti-Fregonara; Jussi Hirvonen; Cheryl Morse; Victor W Pike; Robert B Innis
Journal:  PLoS One       Date:  2011-09-27       Impact factor: 3.240

9.  Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjects.

Authors:  Huailei Jiang; Nicholas R Schmit; Alex R Koenen; Aditya Bansal; Mukesh K Pandey; Robert B Glynn; Bradley J Kemp; Kera L Delaney; Angela Dispenzieri; Jamie N Bakkum-Gamez; Kah-Whye Peng; Stephen J Russell; Tina M Gunderson; Val J Lowe; Timothy R DeGrado
Journal:  EJNMMI Res       Date:  2017-10-27       Impact factor: 3.138

10.  Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [18F]fluortriopride.

Authors:  Robert K Doot; Jacob G Dubroff; Joshua S Scheuermann; Kyle J Labban; Jenny Cai; Chia-Ju Hsieh; Shihong Li; Hsiaoju Lee; Erin K Schubert; Catherine Hou; Regan Sheffer; Alexander Schmitz; Kuiying Xu; Robert H Mach
Journal:  EJNMMI Phys       Date:  2018-10-08
  10 in total
  11 in total

1.  Simultaneous radiomethylation of [11C]harmine and [11C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual.

Authors:  Chrysoula Vraka; Matej Murgaš; Lucas Rischka; Barbara Katharina Geist; Rupert Lanzenberger; Gregor Gryglewski; Thomas Zenz; Wolfgang Wadsak; Markus Mitterhauser; Marcus Hacker; Cécile Philippe; Verena Pichler
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

2.  Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [11C]CHDI-00485180-R and [11C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin.

Authors:  Aline Delva; Michel Koole; Wim Vandenberghe; Koen Van Laere; Kim Serdons; Guy Bormans; Longbin Liu; Jonathan Bard; Vinod Khetarpal; Celia Dominguez; Ignacio Munoz-Sanjuan; Andrew Wood; Mette Skinbjerg; Yuchuan Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-24       Impact factor: 10.057

Review 3.  Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.

Authors:  Aruna Korde; Renata Mikolajczak; Petra Kolenc; Penelope Bouziotis; Hadis Westin; Mette Lauritzen; Michel Koole; Matthias Manfred Herth; Manuel Bardiès; Andre F Martins; Antonio Paulo; Serge K Lyashchenko; Sergio Todde; Sangram Nag; Efthimis Lamprou; Antero Abrunhosa; Francesco Giammarile; Clemens Decristoforo
Journal:  EJNMMI Radiopharm Chem       Date:  2022-07-19

4.  NRM 2021 Abstract Booklet.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2021-12       Impact factor: 6.960

5.  18F-GE180, a failed tracer for translocator protein, has no place in child abuse imaging.

Authors:  Paolo Zanotti-Fregonara; Gaia Rizzo; Mattia Veronese; Robert B Innis; Federico E Turkheimer
Journal:  Pediatr Radiol       Date:  2021-11-27

Review 6.  Radiation Absorbed Dose to the Embryo and Fetus from Radiopharmaceuticals.

Authors:  Paolo Zanotti-Fregonara
Journal:  Semin Nucl Med       Date:  2022-01-21       Impact factor: 4.446

7.  First-in-Human PET Imaging and Estimated Radiation Dosimetry of l-[5-11C]-Glutamine in Patients with Metastatic Colorectal Cancer.

Authors:  Allison S Cohen; Joe Grudzinski; Gary T Smith; Todd E Peterson; Jennifer G Whisenant; Tiffany L Hickman; Kristen K Ciombor; Dana Cardin; Cathy Eng; Laura W Goff; Satya Das; Robert J Coffey; Jordan D Berlin; H Charles Manning
Journal:  J Nucl Med       Date:  2021-04-30       Impact factor: 11.082

Review 8.  Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Authors:  Silvio Aime; Mohammed Al-Qahtani; Martin Behe; Guy Bormans; Giuseppe Carlucci; Jean N DaSilva; Clemens Decristoforo; Adriano Duatti; Philip H Elsinga; Klaus Kopka; Xiang-Guo Li; Zhibo Liu; Robert H Mach; Oskar Middel; Jan Passchier; Marianne Patt; Ivan Penuelas; Ana Rey; Peter J H Scott; Sergio Todde; Jun Toyohara; Danielle Vugts; Zhi Yang
Journal:  EJNMMI Radiopharm Chem       Date:  2021-03-18

Review 9.  Long axial field of view PET scanners: a road map to implementation and new possibilities.

Authors:  Riemer H J A Slart; Charalampos Tsoumpas; Andor W J M Glaudemans; Walter Noordzij; Antoon T M Willemsen; Ronald J H Borra; Rudi A J O Dierckx; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-16       Impact factor: 9.236

Review 10.  Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: Is it time to change the drug development process in order to increase productivity?

Authors:  Tal Burt; Ad F Roffel; Oliver Langer; Kirsten Anderson; Joseph DiMasi
Journal:  Clin Transl Sci       Date:  2022-04-21       Impact factor: 4.438
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.